Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

“I think we are absolutely fucked. I think this country is heading for disaster. I think we’re going to kill thousands of people.” According to Dominic Cummings, those were the words spoken by the then deputy cabinet secretary Helen MacNamara on March 13 2020 when she realised that the UK had no plan for dealing with the unfolding COVID crisis.

And it’s not over yet. The UK’s tally of COVID-19 cases – undoubtedly an underestimate – is now 4.5 million, with over 127,000 COVID deaths. Between half and 1 million people, including 122,000 healthcare workers and 114,000 teachers – give or take a few tens of thousands – remain too sick to work full time. Highly contagious mutant variants, which entered the country recently through ineffective border controls, are spreading exponentially, causing new local outbreaks. Effective prevention measures, such as mask mandates in secondary schools, are being prematurely rolled back. The UK’s third wave is predicted to be small but could yet dwarf the previous two waves.

Read the full article on The Conversation website, written by Professor Trish Greenhalgh, Nuffield Department of Primary Care Health Sciences.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.